Papers: 17 Oct 2014 - 24 Oct 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases. Langer-Gould A, Qian L, Tartof SY, Brara SM, Jacobsen SJ, Beaber BE, Sy LS, Chao C, Hechter R, Tseng H F JAMA Neurol. 2014 Oct 20. PMID: 25329096. Abstract Editors' Pick Motor skill learning requires active central myelination. McKenzie IA, Ohayon D, Li H, de Faria J P, Emery B, Tohyama K, Richardson WD Science. 2014 Oct 17; 346(6207):318-22. Epub 1969 Dec 31. PMID: 25324381. Abstract Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier. Lajoie JM, Shusta EV Annu Rev Pharmacol Toxicol. 2014 Oct 8. PMID: 25340933. Abstract MR venography in patients with multiple sclerosis and correlation with clinical and MRI parameters. Raz E, Pontecorvo S, Barra V, Marincola B C, Morreale M, Tinelli E, Saba L, Di Paolo P L, Aceti A, Catalano C, et al. J Neuroimaging. 2014 Sep-Oct; 24(5):492-7. PMID: 25340182. Abstract Cerebrospinal Venous Outflow in Multiple Sclerosis Patients versus Fatigue and/or Depression. Hagens MHJ, Hoogervorst ELJ, Frequin STFM, Tromp SC Interv Neurol. 2014 Aug; 2(4):193-200. PMID: 25337088. Abstract Clutter management for individuals with multiple sclerosis. Kalina TJ Int J MS Care. 2014 Fall; 16(3):117-22. PMID: 25337053. Abstract A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis. Goodman AD, Brown TR, Schapiro RT, Klingler M, Cohen R, Blight AR Int J MS Care. 2014 Fall; 16(3):153-60. PMID: 25337058. Abstract Exclusive use of alternative medicine as a positive choice: a qualitative study of treatment assumptions among people with multiple sclerosis in denmark. Skovgaard L, Pedersen I K, Verhoef M Int J MS Care. 2014 Fall; 16(3):124-31. PMID: 25337054. Abstract A systematic review of stress-management interventions for multiple sclerosis patients. Reynard AK, Sullivan A B, Rae-Grant A Int J MS Care. 2014 Fall; 16(3):140-4. PMID: 25337056. Abstract Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy. Mirshafiey A, Ghalamfarsa G, Asghari B, Azizi G Innov Clin Neurosci. 2014 Jul; 11(7-8):23-36. PMID: 25337443. Abstract Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis. Nakamura M, Morris M, Cerghet M, Schultz L, Elias S Int J MS Care. 2014 Fall; 16(3):111-5. PMID: 25337052. Abstract Change in perceived health insurance coverage among people with multiple sclerosis. Pozniak A, Hadden L, Rhodes W, Minden S Int J MS Care. 2014 Fall; 16(3):132-9. PMID: 25337055. Abstract Changes in Gross Grasp Strength and Fine Motor Skills in Adolescents with Pediatric Multiple Sclerosis. Squillace M, Ray S, Milazzo M Occup Ther Health Care. 2014 Oct 22. PMID: 25338167. Abstract Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosis. Downing A, Van Ryn D, Fecko A, Aiken C, McGowan S, Sawers S, McInerny T, Moore K, Passariello L, Rogers H Int J MS Care. 2014 Fall; 16(3):146-52. PMID: 25337057. Abstract Pharmaceutical approval update. Gohil K P T. 2014 Oct; 39(10):684-94. PMID: 25336862. Abstract Intracerebroventricular injection of lipopolysaccharide increases gene expression of connexin32 gap junction in rat hippocampus. Abbasian M, Sayyah M, Babapour V, Mahdian R Basic Clin Neurosci. 2013 Fall; 4(4):334-40. PMID: 25337366. Abstract Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature. Miller B, Zirlinger D A Chest. 2014 Oct 1; 146(4_MeetingAbstracts):291A. PMID: 25334304. Abstract Diffuse Granulomatous Inflammation Associated With Long-term Interferon-β Therapy. Yadav H, Lim K Chest. 2014 Oct 1; 146(4_MeetingAbstracts):389A. PMID: 25334411. Abstract Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis. Chirapapaisan N, Laotaweerungsawat S, Chuenkongkaew W, Samsen P, Ruangvaravate N, Thuangtong A, Chanvarapha N Doc Ophthalmol. 2014 Oct 21. PMID: 25330954. Abstract Redox regulation of NF-κB p50 and M1 polarization in microglia. Taetzsch T, Levesque S, McGraw C, Brookins S, Luqa R, Bonini MG, Mason RP, Oh U, Block ML Glia. 2014 Oct 21. PMID: 25331559. Abstract Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis. Moreno Torres I, Sanchez AJ, Garcia-Merino A Expert Rev Neurother. 2014 Nov; 14(11):1243-50. PMID: 25331416. Abstract Remyelinating strategies in multiple sclerosis. Luessi F, Kuhlmann T, Zipp F Expert Rev Neurother. 2014 Nov; 14(11):1315-34. PMID: 25331418. Abstract Use of Functional Ambulation Performance Score as measurement of gait ability: Review. Gouelle A J Rehabil Res Dev. 2014; 51(5):665-74. PMID: 25333744. Abstract Correction: deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model. PLOS ONE Staff PLoS One. 2014; 9(10):e111828. Epub 2014 Oct 22. PMID: 25338078. Abstract Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption. Johnson HL, Willenbring RC, Jin F, Manhart WA, LaFrance SJ, Pirko I, Johnson AJ PLoS One. 2014; 9(10):e111401. Epub 2014 Oct 22. PMID: 25337791. Abstract Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Aw W, Fukuda S Semin Immunopathol. 2014 Oct 22. Epub 2014 Oct 22. PMID: 25338280. Abstract Microglia - performers of the 21st century. Atallah N, Vasiu R, Boşca A B, CreŢu D I, Georgiu C, Constantin A M, Sovrea A S Rom J Morphol Embryol. 2014; 55(3):745-65. PMID: 25329100. Abstract Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Xie L, Choudhury G R, Winters A, Yang S-H, Jin K Eur J Immunol. 2014 Oct 20. PMID: 25329858. Abstract Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature. Patel DP, Elliott SP, Stoffel JT, Brant WO, Hotaling JM, Myers JB Neurourol Urodyn. 2014 Oct 18. PMID: 25327455. Abstract Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort. Alroughani RA, Akhtar S, Ahmed SF, Al-Hashel JY Int J Neurosci. 2014 Oct 20:1-17. PMID: 25329929. Abstract Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b. Yu L, Croze E, Yamaguchi KD, Tran T, Reder AT, Litvak V, Volkert MR J Interferon Cytokine Res. 2014 Oct 20. PMID: 25330068. Abstract Long-term effectiveness of combined cognitive-behavioral and neuropsychological intervention in a case of multiple sclerosis. Martínez-González A E, Piqueras J A Neurocase. 2014 Oct 20:1-8. PMID: 25330097. Abstract Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy. Ettler J, Arenberger P, Arenbergerova M, Gkalpakiotis S J Eur Acad Dermatol Venereol. 2014 Oct 20. PMID: 25327640. Abstract Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis. Zhang X, Hay JW, Niu X CNS Drugs. 2014 Oct 19. PMID: 25326785. Abstract Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation. Jonas A, Thiem S, Kuhlmann T, Wagener R, Aszodi A, Nowell C, Hagemeier K, Laverick L, Perreau V, Jokubaitis V, et al. J Clin Invest. 2014 Nov 3; 124(11):5042-5056. Epub 2014 Oct 20. PMID: 25329699. Abstract Do We Need Worms to Promote Immune Health? Weinstock JV Clin Rev Allergy Immunol. 2014 Oct 19. PMID: 25326880. Abstract Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis. Mandolesi G, Gentile A, Musella A, Centonze D Cerebellum. 2014 Oct 19. PMID: 25326653. Abstract Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging. Primiani CT, Ryan VH, Rao JS, Cam MC, Ahn K, Modi HR, Rapoport SI PLoS One. 2014; 9(10):e110972. Epub 2014 Oct 20. PMID: 25329999. Abstract MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6. Ebrahimi-Kalan A, Soleimani Rad J, Kafami L, Mohammadnejad D, Habibi Roudkenar M, Khaki A A, Aliyari Serej Z, Mohammadi Roushandeh A Iran Biomed J. 2014 Oct; 18(4):196-202. PMID: 25326017. Abstract Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis. Tada S, Okuno T, Hitoshi Y, Yasui T, Honorat J, Takata K, Koda T, Shimagami H, Chi-Jing C, Namba A, et al. J Neuroinflammation. 2014 Oct 19; 11(1):179. Epub 2014 Oct 19. PMID: 25326688. Abstract Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis. Schwab N, Schneider-Hohendorf T, Wiendl H Int Immunol. 2014 Oct 17. PMID: 25326459. Abstract Expression of a Second Ecto-5'-Nucleotidase Variant Besides the Usual Protein in Symptomatic Phase of Experimental Autoimmune Encephalomyelitis. Lavrnja I, Laketa D, Savic D, Bozic I, Bjelobaba I, Pekovic S, Nedeljkovic N J Mol Neurosci. 2014 Oct 19. Epub 2014 Oct 19. PMID: 25326791. Abstract Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program. Jafarzadeh A, Jamali M, Mahdavi R, Ebrahimi HA, Hajghani H, Khosravimashizi A, Nemati M, Najafipour H, Sheikhi A, Mohammadi MM, et al. J Mol Neurosci. 2014 Oct 19. Epub 2014 Oct 19. PMID: 25326790. Abstract Hughes syndrome and Multiple sclerosis. Uthman I, Noureldine MHA, Berjawi A, Skaf M, Haydar AA, Merashli M, Hughes GRV Lupus. 2014 Oct 17. PMID: 25326228. Abstract Effects of Coenzyme Q10 on the ratio of TH1/TH2 in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in C57BL/6. Soleimani M, Jameie S B, Barati M, Mehdizadeh M, Kerdari M Iran Biomed J. 2014 Oct; 18(4):203-11. PMID: 25326018. Abstract Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis. Villar LM, Picón C, Costa-Frossard L, Alenda R, García-Caldentey J, Espiño M, Muriel A, Alvarez-Cermeño JC Eur J Neurol. 2014 Oct 17. PMID: 25324032. Abstract Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study. Rasova K, Prochazkova M, Tintera J, Ibrahim I, Zimova D, Stetkarova I Int J Rehabil Res. 2014 Oct 16. PMID: 25325167. Abstract Dietary Sutherlandia and Elderberry Mitigate Cerebral Ischemia-Induced Neuronal Damage and Attenuate p47phox and Phospho-ERK1/2 Expression in Microglial Cells. Chuang DY, Cui J, Simonyi A, Engel VA, Chen S, Fritsche KL, Thomas AL, Applequist WL, Folk WR, Lubahn DB, et al. ASN Neuro. 2014 Oct; 6(6). PMID: 25324465. Abstract Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk. Hedström A K, Bomfim I L, Barcellos LF, Briggs F, Schaefer C, Kockum I, Olsson T, Alfredsson L Int J Epidemiol. 2014 Oct 15. PMID: 25324153. Abstract Underrecognition of Sleep Disorders in Patients with Multiple Sclerosis. Braley TJ, Segal BM, Chervin RD J Clin Sleep Med. 2014 Oct 17. PMID: 25325587. Abstract Estimating typical multiple sclerosis disability progression speed from clinical observations. Brown MG, Asbridge M, Hicks V, Kirby S, Murray TJ, Andreou P, Lin D PLoS One. 2014; 9(10):e105123. Epub 2014 Oct 17. PMID: 25329469. Abstract Anti-Inflammatory Potential of Newly Synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in Lipopolysaccharide-Stimulated BV2 Microglia. Jo G-H, Choi I-W, Jeong J-W, Kim G-Y, Kim J, Suh H, Ryu C-H, Kim W-J, Choi Y H Molecules. 2014; 19(10):16609-23. PMID: 25322283. Abstract Exacerbation of Autoimmune Neuro-Inflammation in Mice Cured from Blood-Stage Plasmodium berghei Infection. Thomé R, Bombeiro A L, Issayama L K, Rapôso C, Lopes S C P, da Costa T A, Di Gangi R, Ferreira I T, Longhini A L F, Oliveira A L R, et al. PLoS One. 2014; 9(10):e110739. Epub 2014 Oct 17. PMID: 25329161. Abstract Sample size estimation for negative binomial regression comparing rates of recurrent events with unequal follow-up time. Tang Y J Biopharm Stat. 2014 Oct 16. PMID: 25322146. Abstract Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada. Torabi M, Green C, Yu N, Marrie R A Neuroepidemiology. 2014; 43(1):38-48. Epub 2014 Oct 16. PMID: 25323329. Abstract Patient with Neuromyelitis Optica Spectrum Disorder Combined with Sjögren's Syndrome Relapse Free Following Tacrolimus Treatment. Zheng X, Zhang X, Liu X J, Mu W, Yang W, Liu Y, Ge P, Li H Intern Med. 2014; 53(20):2377-80. Epub 2014 Oct 15. PMID: 25318807. Abstract JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level. Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V Ther Clin Risk Manag. 2014; 10:807-14. Epub 2014 Oct 09. PMID: 25328396. Abstract Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO. Gelfand JM, Cotter J, Klingman J, Huang EJ, Cree BAC Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e34. Epub 2014 Oct 09. PMID: 25340086. Abstract Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? Fujihara K, Nakashima I Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e38. Epub 2014 Oct 09. PMID: 25340089. Abstract Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis. Uysal U, Idiman F, Idiman E, Ozakbas S, Karakas S, Bruce J J Clin Neurol. 2014 Oct; 10(4):296-303. Epub 2014 Oct 06. PMID: 25324878. Abstract Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients. Fleischer V, Salmen A, Kollar S, Weyer V, Siffrin V, Chan A, Zipp F, Luessi F J Clin Neurol. 2014 Oct; 10(4):289-95. Epub 2014 Oct 06. PMID: 25324877. Abstract Hyperhomocysteinemia and neurologic disorders: a review. Ansari R, Mahta A, Mallack E, Luo J J J Clin Neurol. 2014 Oct; 10(4):281-8. Epub 2014 Oct 06. PMID: 25324876. Abstract Multiple sclerosis: overview of disease-modifying agents. Finkelsztejn A Perspect Medicin Chem. 2014; 6:65-72. Epub 2014 Oct 05. PMID: 25336899. Abstract Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey. Williams AE, Vietri JT, Isherwood G, Flor A Mult Scler Int. 2014; 2014:203183. Epub 2014 Sep 23. PMID: 25328704. Abstract Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis. Thomas K, Dietze K, Wehner R, Metz I, Tumani H, Schultheiß T, Günther C, Schäkel K, Reichmann H, Brück W, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e33. Epub 2014 Sep 18. PMID: 25340085. Abstract IV immunoglobulin confounds JC virus antibody serostatus determination. Kister I, Kuesters G, Chamot E, Omari M, Dontas K, Yarussi M, Subramanyam M, Herbert J Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e29. Epub 2014 Sep 18. PMID: 25340081. Abstract Remyelination therapy goes to trial for multiple sclerosis. Brugarolas P, Popko B Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e26. Epub 2014 Aug 21. PMID: 25340076. Abstract Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS. Torkildsen O, Myhr K-M, Wergeland S Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e25. Epub 2014 Aug 21. PMID: 25340078. Abstract MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS. Varrin-Doyer M, Shetty A, Spencer CM, Schulze-Topphoff U, Weber MS, Bernard CCA, Forsthuber T, Cree BAC, Slavin AJ, Zamvil SS Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e20. Epub 2014 Aug 14. PMID: 25340072. Abstract CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis. Mir F, Lee D, Ray H, Sadiq SA Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e21. Epub 2014 Aug 14. PMID: 25340073. Abstract Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE. Shetty A, Gupta SG, Varrin-Doyer M, Weber MS, Prod'homme T, Molnarfi N, Ji N, Nelson PA, Patarroyo JC, Schulze-Topphoff U, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e22. Epub 2014 Aug 14. PMID: 25340074. Abstract AQP4 autoantibody assay performance in clinical laboratory service. Fryer JP, Lennon VA, Pittock SJ, Jenkins SM, Fallier-Becker P, Clardy SL, Horta E, Jedynak EA, Lucchinetti CF, Shuster EA, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e11. Epub 2014 May 22. PMID: 25340055. Abstract Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Dale RC, Tantsis EM, Merheb V, Kumaran R-YA, Sinmaz N, Pathmanandavel K, Ramanathan S, Booth DR, Wienholt LA, Prelog K, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e12. Epub 2014 May 22. PMID: 25340056. Abstract NMDA receptor antibodies associated with distinct white matter syndromes. Hacohen Y, Absoud M, Hemingway C, Jacobson L, Lin J-P, Pike M, Pullaperuma S, Siddiqui A, Wassmer E, Waters P, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e2. Epub 2014 Apr 24. PMID: 25340058. Abstract Predictors of recurrence following an initial episode of transverse myelitis. Kimbrough DJ, Mealy MA, Simpson A, Levy M Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e4. Epub 2014 Apr 24. PMID: 25340060. Abstract Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica. Levy M, Mealy MA Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e5. Epub 2014 Apr 24. PMID: 25340061. Abstract Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy. Gattringer T, Enzinger C, Khalil M, Schwingenschuh P, Pichler A, Moser A, Graninger W, Ernst C, Haybaeck J, Fazekas F Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e1. Epub 2014 Apr 24. PMID: 25340053. Abstract
Editors' Pick Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases. Langer-Gould A, Qian L, Tartof SY, Brara SM, Jacobsen SJ, Beaber BE, Sy LS, Chao C, Hechter R, Tseng H F JAMA Neurol. 2014 Oct 20. PMID: 25329096. Abstract
Editors' Pick Motor skill learning requires active central myelination. McKenzie IA, Ohayon D, Li H, de Faria J P, Emery B, Tohyama K, Richardson WD Science. 2014 Oct 17; 346(6207):318-22. Epub 1969 Dec 31. PMID: 25324381. Abstract
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier. Lajoie JM, Shusta EV Annu Rev Pharmacol Toxicol. 2014 Oct 8. PMID: 25340933. Abstract
MR venography in patients with multiple sclerosis and correlation with clinical and MRI parameters. Raz E, Pontecorvo S, Barra V, Marincola B C, Morreale M, Tinelli E, Saba L, Di Paolo P L, Aceti A, Catalano C, et al. J Neuroimaging. 2014 Sep-Oct; 24(5):492-7. PMID: 25340182. Abstract
Cerebrospinal Venous Outflow in Multiple Sclerosis Patients versus Fatigue and/or Depression. Hagens MHJ, Hoogervorst ELJ, Frequin STFM, Tromp SC Interv Neurol. 2014 Aug; 2(4):193-200. PMID: 25337088. Abstract
Clutter management for individuals with multiple sclerosis. Kalina TJ Int J MS Care. 2014 Fall; 16(3):117-22. PMID: 25337053. Abstract
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis. Goodman AD, Brown TR, Schapiro RT, Klingler M, Cohen R, Blight AR Int J MS Care. 2014 Fall; 16(3):153-60. PMID: 25337058. Abstract
Exclusive use of alternative medicine as a positive choice: a qualitative study of treatment assumptions among people with multiple sclerosis in denmark. Skovgaard L, Pedersen I K, Verhoef M Int J MS Care. 2014 Fall; 16(3):124-31. PMID: 25337054. Abstract
A systematic review of stress-management interventions for multiple sclerosis patients. Reynard AK, Sullivan A B, Rae-Grant A Int J MS Care. 2014 Fall; 16(3):140-4. PMID: 25337056. Abstract
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy. Mirshafiey A, Ghalamfarsa G, Asghari B, Azizi G Innov Clin Neurosci. 2014 Jul; 11(7-8):23-36. PMID: 25337443. Abstract
Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis. Nakamura M, Morris M, Cerghet M, Schultz L, Elias S Int J MS Care. 2014 Fall; 16(3):111-5. PMID: 25337052. Abstract
Change in perceived health insurance coverage among people with multiple sclerosis. Pozniak A, Hadden L, Rhodes W, Minden S Int J MS Care. 2014 Fall; 16(3):132-9. PMID: 25337055. Abstract
Changes in Gross Grasp Strength and Fine Motor Skills in Adolescents with Pediatric Multiple Sclerosis. Squillace M, Ray S, Milazzo M Occup Ther Health Care. 2014 Oct 22. PMID: 25338167. Abstract
Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosis. Downing A, Van Ryn D, Fecko A, Aiken C, McGowan S, Sawers S, McInerny T, Moore K, Passariello L, Rogers H Int J MS Care. 2014 Fall; 16(3):146-52. PMID: 25337057. Abstract
Intracerebroventricular injection of lipopolysaccharide increases gene expression of connexin32 gap junction in rat hippocampus. Abbasian M, Sayyah M, Babapour V, Mahdian R Basic Clin Neurosci. 2013 Fall; 4(4):334-40. PMID: 25337366. Abstract
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature. Miller B, Zirlinger D A Chest. 2014 Oct 1; 146(4_MeetingAbstracts):291A. PMID: 25334304. Abstract
Diffuse Granulomatous Inflammation Associated With Long-term Interferon-β Therapy. Yadav H, Lim K Chest. 2014 Oct 1; 146(4_MeetingAbstracts):389A. PMID: 25334411. Abstract
Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis. Chirapapaisan N, Laotaweerungsawat S, Chuenkongkaew W, Samsen P, Ruangvaravate N, Thuangtong A, Chanvarapha N Doc Ophthalmol. 2014 Oct 21. PMID: 25330954. Abstract
Redox regulation of NF-κB p50 and M1 polarization in microglia. Taetzsch T, Levesque S, McGraw C, Brookins S, Luqa R, Bonini MG, Mason RP, Oh U, Block ML Glia. 2014 Oct 21. PMID: 25331559. Abstract
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis. Moreno Torres I, Sanchez AJ, Garcia-Merino A Expert Rev Neurother. 2014 Nov; 14(11):1243-50. PMID: 25331416. Abstract
Remyelinating strategies in multiple sclerosis. Luessi F, Kuhlmann T, Zipp F Expert Rev Neurother. 2014 Nov; 14(11):1315-34. PMID: 25331418. Abstract
Use of Functional Ambulation Performance Score as measurement of gait ability: Review. Gouelle A J Rehabil Res Dev. 2014; 51(5):665-74. PMID: 25333744. Abstract
Correction: deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model. PLOS ONE Staff PLoS One. 2014; 9(10):e111828. Epub 2014 Oct 22. PMID: 25338078. Abstract
Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption. Johnson HL, Willenbring RC, Jin F, Manhart WA, LaFrance SJ, Pirko I, Johnson AJ PLoS One. 2014; 9(10):e111401. Epub 2014 Oct 22. PMID: 25337791. Abstract
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Aw W, Fukuda S Semin Immunopathol. 2014 Oct 22. Epub 2014 Oct 22. PMID: 25338280. Abstract
Microglia - performers of the 21st century. Atallah N, Vasiu R, Boşca A B, CreŢu D I, Georgiu C, Constantin A M, Sovrea A S Rom J Morphol Embryol. 2014; 55(3):745-65. PMID: 25329100. Abstract
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Xie L, Choudhury G R, Winters A, Yang S-H, Jin K Eur J Immunol. 2014 Oct 20. PMID: 25329858. Abstract
Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature. Patel DP, Elliott SP, Stoffel JT, Brant WO, Hotaling JM, Myers JB Neurourol Urodyn. 2014 Oct 18. PMID: 25327455. Abstract
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort. Alroughani RA, Akhtar S, Ahmed SF, Al-Hashel JY Int J Neurosci. 2014 Oct 20:1-17. PMID: 25329929. Abstract
Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b. Yu L, Croze E, Yamaguchi KD, Tran T, Reder AT, Litvak V, Volkert MR J Interferon Cytokine Res. 2014 Oct 20. PMID: 25330068. Abstract
Long-term effectiveness of combined cognitive-behavioral and neuropsychological intervention in a case of multiple sclerosis. Martínez-González A E, Piqueras J A Neurocase. 2014 Oct 20:1-8. PMID: 25330097. Abstract
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy. Ettler J, Arenberger P, Arenbergerova M, Gkalpakiotis S J Eur Acad Dermatol Venereol. 2014 Oct 20. PMID: 25327640. Abstract
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis. Zhang X, Hay JW, Niu X CNS Drugs. 2014 Oct 19. PMID: 25326785. Abstract
Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation. Jonas A, Thiem S, Kuhlmann T, Wagener R, Aszodi A, Nowell C, Hagemeier K, Laverick L, Perreau V, Jokubaitis V, et al. J Clin Invest. 2014 Nov 3; 124(11):5042-5056. Epub 2014 Oct 20. PMID: 25329699. Abstract
Do We Need Worms to Promote Immune Health? Weinstock JV Clin Rev Allergy Immunol. 2014 Oct 19. PMID: 25326880. Abstract
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis. Mandolesi G, Gentile A, Musella A, Centonze D Cerebellum. 2014 Oct 19. PMID: 25326653. Abstract
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging. Primiani CT, Ryan VH, Rao JS, Cam MC, Ahn K, Modi HR, Rapoport SI PLoS One. 2014; 9(10):e110972. Epub 2014 Oct 20. PMID: 25329999. Abstract
MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6. Ebrahimi-Kalan A, Soleimani Rad J, Kafami L, Mohammadnejad D, Habibi Roudkenar M, Khaki A A, Aliyari Serej Z, Mohammadi Roushandeh A Iran Biomed J. 2014 Oct; 18(4):196-202. PMID: 25326017. Abstract
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis. Tada S, Okuno T, Hitoshi Y, Yasui T, Honorat J, Takata K, Koda T, Shimagami H, Chi-Jing C, Namba A, et al. J Neuroinflammation. 2014 Oct 19; 11(1):179. Epub 2014 Oct 19. PMID: 25326688. Abstract
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis. Schwab N, Schneider-Hohendorf T, Wiendl H Int Immunol. 2014 Oct 17. PMID: 25326459. Abstract
Expression of a Second Ecto-5'-Nucleotidase Variant Besides the Usual Protein in Symptomatic Phase of Experimental Autoimmune Encephalomyelitis. Lavrnja I, Laketa D, Savic D, Bozic I, Bjelobaba I, Pekovic S, Nedeljkovic N J Mol Neurosci. 2014 Oct 19. Epub 2014 Oct 19. PMID: 25326791. Abstract
Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program. Jafarzadeh A, Jamali M, Mahdavi R, Ebrahimi HA, Hajghani H, Khosravimashizi A, Nemati M, Najafipour H, Sheikhi A, Mohammadi MM, et al. J Mol Neurosci. 2014 Oct 19. Epub 2014 Oct 19. PMID: 25326790. Abstract
Hughes syndrome and Multiple sclerosis. Uthman I, Noureldine MHA, Berjawi A, Skaf M, Haydar AA, Merashli M, Hughes GRV Lupus. 2014 Oct 17. PMID: 25326228. Abstract
Effects of Coenzyme Q10 on the ratio of TH1/TH2 in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in C57BL/6. Soleimani M, Jameie S B, Barati M, Mehdizadeh M, Kerdari M Iran Biomed J. 2014 Oct; 18(4):203-11. PMID: 25326018. Abstract
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis. Villar LM, Picón C, Costa-Frossard L, Alenda R, García-Caldentey J, Espiño M, Muriel A, Alvarez-Cermeño JC Eur J Neurol. 2014 Oct 17. PMID: 25324032. Abstract
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study. Rasova K, Prochazkova M, Tintera J, Ibrahim I, Zimova D, Stetkarova I Int J Rehabil Res. 2014 Oct 16. PMID: 25325167. Abstract
Dietary Sutherlandia and Elderberry Mitigate Cerebral Ischemia-Induced Neuronal Damage and Attenuate p47phox and Phospho-ERK1/2 Expression in Microglial Cells. Chuang DY, Cui J, Simonyi A, Engel VA, Chen S, Fritsche KL, Thomas AL, Applequist WL, Folk WR, Lubahn DB, et al. ASN Neuro. 2014 Oct; 6(6). PMID: 25324465. Abstract
Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk. Hedström A K, Bomfim I L, Barcellos LF, Briggs F, Schaefer C, Kockum I, Olsson T, Alfredsson L Int J Epidemiol. 2014 Oct 15. PMID: 25324153. Abstract
Underrecognition of Sleep Disorders in Patients with Multiple Sclerosis. Braley TJ, Segal BM, Chervin RD J Clin Sleep Med. 2014 Oct 17. PMID: 25325587. Abstract
Estimating typical multiple sclerosis disability progression speed from clinical observations. Brown MG, Asbridge M, Hicks V, Kirby S, Murray TJ, Andreou P, Lin D PLoS One. 2014; 9(10):e105123. Epub 2014 Oct 17. PMID: 25329469. Abstract
Anti-Inflammatory Potential of Newly Synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in Lipopolysaccharide-Stimulated BV2 Microglia. Jo G-H, Choi I-W, Jeong J-W, Kim G-Y, Kim J, Suh H, Ryu C-H, Kim W-J, Choi Y H Molecules. 2014; 19(10):16609-23. PMID: 25322283. Abstract
Exacerbation of Autoimmune Neuro-Inflammation in Mice Cured from Blood-Stage Plasmodium berghei Infection. Thomé R, Bombeiro A L, Issayama L K, Rapôso C, Lopes S C P, da Costa T A, Di Gangi R, Ferreira I T, Longhini A L F, Oliveira A L R, et al. PLoS One. 2014; 9(10):e110739. Epub 2014 Oct 17. PMID: 25329161. Abstract
Sample size estimation for negative binomial regression comparing rates of recurrent events with unequal follow-up time. Tang Y J Biopharm Stat. 2014 Oct 16. PMID: 25322146. Abstract
Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada. Torabi M, Green C, Yu N, Marrie R A Neuroepidemiology. 2014; 43(1):38-48. Epub 2014 Oct 16. PMID: 25323329. Abstract
Patient with Neuromyelitis Optica Spectrum Disorder Combined with Sjögren's Syndrome Relapse Free Following Tacrolimus Treatment. Zheng X, Zhang X, Liu X J, Mu W, Yang W, Liu Y, Ge P, Li H Intern Med. 2014; 53(20):2377-80. Epub 2014 Oct 15. PMID: 25318807. Abstract
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level. Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V Ther Clin Risk Manag. 2014; 10:807-14. Epub 2014 Oct 09. PMID: 25328396. Abstract
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO. Gelfand JM, Cotter J, Klingman J, Huang EJ, Cree BAC Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e34. Epub 2014 Oct 09. PMID: 25340086. Abstract
Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? Fujihara K, Nakashima I Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e38. Epub 2014 Oct 09. PMID: 25340089. Abstract
Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis. Uysal U, Idiman F, Idiman E, Ozakbas S, Karakas S, Bruce J J Clin Neurol. 2014 Oct; 10(4):296-303. Epub 2014 Oct 06. PMID: 25324878. Abstract
Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients. Fleischer V, Salmen A, Kollar S, Weyer V, Siffrin V, Chan A, Zipp F, Luessi F J Clin Neurol. 2014 Oct; 10(4):289-95. Epub 2014 Oct 06. PMID: 25324877. Abstract
Hyperhomocysteinemia and neurologic disorders: a review. Ansari R, Mahta A, Mallack E, Luo J J J Clin Neurol. 2014 Oct; 10(4):281-8. Epub 2014 Oct 06. PMID: 25324876. Abstract
Multiple sclerosis: overview of disease-modifying agents. Finkelsztejn A Perspect Medicin Chem. 2014; 6:65-72. Epub 2014 Oct 05. PMID: 25336899. Abstract
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey. Williams AE, Vietri JT, Isherwood G, Flor A Mult Scler Int. 2014; 2014:203183. Epub 2014 Sep 23. PMID: 25328704. Abstract
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis. Thomas K, Dietze K, Wehner R, Metz I, Tumani H, Schultheiß T, Günther C, Schäkel K, Reichmann H, Brück W, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e33. Epub 2014 Sep 18. PMID: 25340085. Abstract
IV immunoglobulin confounds JC virus antibody serostatus determination. Kister I, Kuesters G, Chamot E, Omari M, Dontas K, Yarussi M, Subramanyam M, Herbert J Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e29. Epub 2014 Sep 18. PMID: 25340081. Abstract
Remyelination therapy goes to trial for multiple sclerosis. Brugarolas P, Popko B Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e26. Epub 2014 Aug 21. PMID: 25340076. Abstract
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS. Torkildsen O, Myhr K-M, Wergeland S Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e25. Epub 2014 Aug 21. PMID: 25340078. Abstract
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS. Varrin-Doyer M, Shetty A, Spencer CM, Schulze-Topphoff U, Weber MS, Bernard CCA, Forsthuber T, Cree BAC, Slavin AJ, Zamvil SS Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e20. Epub 2014 Aug 14. PMID: 25340072. Abstract
CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis. Mir F, Lee D, Ray H, Sadiq SA Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e21. Epub 2014 Aug 14. PMID: 25340073. Abstract
Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE. Shetty A, Gupta SG, Varrin-Doyer M, Weber MS, Prod'homme T, Molnarfi N, Ji N, Nelson PA, Patarroyo JC, Schulze-Topphoff U, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e22. Epub 2014 Aug 14. PMID: 25340074. Abstract
AQP4 autoantibody assay performance in clinical laboratory service. Fryer JP, Lennon VA, Pittock SJ, Jenkins SM, Fallier-Becker P, Clardy SL, Horta E, Jedynak EA, Lucchinetti CF, Shuster EA, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e11. Epub 2014 May 22. PMID: 25340055. Abstract
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Dale RC, Tantsis EM, Merheb V, Kumaran R-YA, Sinmaz N, Pathmanandavel K, Ramanathan S, Booth DR, Wienholt LA, Prelog K, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e12. Epub 2014 May 22. PMID: 25340056. Abstract
NMDA receptor antibodies associated with distinct white matter syndromes. Hacohen Y, Absoud M, Hemingway C, Jacobson L, Lin J-P, Pike M, Pullaperuma S, Siddiqui A, Wassmer E, Waters P, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e2. Epub 2014 Apr 24. PMID: 25340058. Abstract
Predictors of recurrence following an initial episode of transverse myelitis. Kimbrough DJ, Mealy MA, Simpson A, Levy M Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e4. Epub 2014 Apr 24. PMID: 25340060. Abstract
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica. Levy M, Mealy MA Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e5. Epub 2014 Apr 24. PMID: 25340061. Abstract
Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy. Gattringer T, Enzinger C, Khalil M, Schwingenschuh P, Pichler A, Moser A, Graninger W, Ernst C, Haybaeck J, Fazekas F Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e1. Epub 2014 Apr 24. PMID: 25340053. Abstract